Definitive Contract 75N91024C00062
Award Date
9/15/24
Potential Completion Date
9/14/25
Potential Value
$398K
Federal Agency
National Cancer Institute
Awardee
Standard Imaging Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Middleton, WI 53562, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute awarded a $399,504 Small Business Innovation Research (SBIR) Phase I contract to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software, for the development of a novel NIST-traceable ionization chamber for flash dosimetry. This award is related to SBIR Topic 434 from a broader NIH/CDC SBIR solicitation focused on advancing research and development to support the agencies' infectious disease, cancer, aging, and public...
The National Cancer Institute (NCI) has awarded a $1,222,441.00 Firm Fixed Price SBIR Phase II contract to Standard Imaging Inc., a small business manufacturer of specialized radiation measurement equipment and software. The contract, identified as 75N91024C00097, is for the development of a "Novel NIST Traceable Ionization Chamber for Flash Dosimetry" under SBIR Topic No. 434. This contract, set aside for small businesses, aims to advance the field of radiation measurement and therapy...
This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...
This is a Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Tetraimaging LLC, a self-certified small disadvantaged business. The contract, valued at $1,999,930.00, is for the development of a multilayer strip ion chamber device to measure flash-RT beams under the SBIR (Small Business Innovation Research) Program Phase II. The period of performance is from September 16, 2024, to September 15, 2026, and the contract has a total small...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Healthmyne, Inc., a for-profit small business organization. The contract, valued at $225,000.00, is a definitive firm fixed-price contract related to the "QIDS: USING RADIOMICS TO IMPACT RADIOTHERAPY TREATMENT PLANNING - MOONSHOT" effort, which was originally solicited under the National Institutes of Health and Centers for Disease Control and...